Mackenzie Financial’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.5K | Sell |
11,700
-111,415
| -90% | -$110K | ﹤0.01% | 1683 |
|
|
2025
Q1 | $177K | Sell |
123,115
-20,137
| -14% | -$29K | ﹤0.01% | 1537 |
|
|
2024
Q4 | $315K | Buy |
143,252
+76,965
| +116% | +$169K | ﹤0.01% | 1362 |
|
|
2024
Q3 | $109K | Buy |
66,287
+31,033
| +88% | +$51.2K | ﹤0.01% | 1472 |
|
|
2024
Q2 | $78.3K | Buy |
35,254
+18,036
| +105% | +$40K | ﹤0.01% | 1456 |
|
|
2024
Q1 | $46.1K | Buy |
17,218
+3,827
| +29% | +$10.3K | ﹤0.01% | 1487 |
|
|
2023
Q4 | $40K | Sell |
13,391
-19,227
| -59% | -$57.5K | ﹤0.01% | 1458 |
|
|
2023
Q3 | $31.5K | Buy |
32,618
+5,341
| +20% | +$5.17K | ﹤0.01% | 1437 |
|
|
2023
Q2 | $38.7K | Sell |
27,277
-60,060
| -69% | -$85.3K | ﹤0.01% | 1474 |
|
|
2023
Q1 | $139K | Buy |
87,337
+19,494
| +29% | +$31K | ﹤0.01% | 1379 |
|
|
2022
Q4 | $423K | Buy |
+67,843
| New | +$423K | ﹤0.01% | 983 |
|